Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 390,174,112
  • Shares Outstanding, K 2,682,900
  • Annual Sales, $ 76,450 M
  • Annual Income, $ 1,300 M
  • 36-Month Beta 0.59
  • Price/Sales 5.12
  • Price/Cash Flow 15.28
  • Price/Book 6.06

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 1.95
  • Number of Estimates 7
  • High Estimate 1.97
  • Low Estimate 1.93
  • Prior Year 1.74
  • Growth Rate Est. (year over year) +12.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
139.66 +4.13%
on 11/27/18
148.99 -2.39%
on 12/04/18
+0.68 (+0.47%)
since 11/07/18
3-Month
132.23 +9.98%
on 10/12/18
148.99 -2.39%
on 12/04/18
+8.11 (+5.91%)
since 09/07/18
52-Week
118.62 +22.60%
on 05/29/18
148.99 -2.39%
on 12/04/18
+5.42 (+3.87%)
since 12/07/17

Most Recent Stories

More News
Dow 30 Stock Roundup: Apple Likely to Delay 5G iPhone Launch, Exxon Finds Oil in Pluma-1 Exploration Well

The Dow traversed a rough holiday-shortened week, marked by the return of trade war fears.

AAPL : 168.49 (-3.57%)
VZ : 57.68 (-0.69%)
QCOM : 55.99 (-1.96%)
INTC : 46.24 (-4.40%)
JNJ : 145.43 (-0.33%)
XOM : 77.64 (-0.96%)
PG : 92.45 (-1.18%)
DWDP : 53.75 (-3.88%)
Johnson & Johnson (JNJ) Stock Moves -0.08%: What You Should Know

Johnson & Johnson (JNJ) closed at $145.91 in the latest trading session, marking a -0.08% move from the prior day.

JNJ : 145.43 (-0.33%)
Global Mouthwash Market Outlook to 2023 - Key Players are Colgate-Palmolive Company, GlaxoSmithKline, Johnson & Johnson Services, Procter & Gamble and Unilever - ResearchAndMarkets.com

The "Global Mouthwash Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

JNJ : 145.43 (-0.33%)
GSK : 37.30 (-0.32%)
Watch for Johnson&Johnson to Potentially Rebound After Falling 1.27% Yesterday

Johnson&Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $144.10 to a high of $146.45. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $144.94...

JNJ : 145.43 (-0.33%)
After Yesterday's Decline of 1.27%, Johnson&Johnson Offers Investors Better Value

Johnson&Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $144.10 to a high of $146.45. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $144.94...

JNJ : 145.43 (-0.33%)
AbbVie Halts Rova-T Phase III Second-Line Lung Cancer Study

IDMC recommends AbbVie (ABBV) to stop enrolment in a late-stage study on its small cell lung cancer candidate, Rova-T.

MRK : 76.72 (-2.11%)
JNJ : 145.43 (-0.33%)
ABBV : 86.96 (-3.73%)
RHHBY : 31.5000 (-0.54%)
BIP Asia Forum Opens Today

INOTF : 0.0238 (-23.23%)
PCRFY : 9.7050 (-2.95%)
JNJ : 145.43 (-0.33%)
NOK : 5.53 (-1.60%)
NSRGF : 85.9100 (+2.82%)
The St. Joe Company and Johnson & Johnson (dba Busy Bee) Announce Plans for a Busy Bee Branded Fuel Station and Convenience Store in Panama City Beach

The St. Joe Company (NYSE: JOE) ("St. Joe") and Johnson & Johnson, Inc. ("Johnson & Johnson") today announced their intent to pursue formation of a joint venture to construct, own and manage...

JOE : 14.01 (-5.91%)
JNJ : 145.43 (-0.33%)
J&J's Blood Cancer Drugs Succeed in Label Expansion Studies

J&J (JNJ) presents positive data from late-stage studies evaluating its blood cancer drugs, Imbruvica and Darzalex, in the first-line setting at ASH.

CELG : 70.08 (-3.74%)
JNJ : 145.43 (-0.33%)
ABBV : 86.96 (-3.73%)
RHHBY : 31.5000 (-0.54%)
Mylan Expands Recall of Valsartan to All Unexpired Lots

Mylan (MYL) expands recall of batches of blood pressure medicine in the United States to include all Valsartan-based products within expiry.

MYL : 30.55 (-4.05%)
JNJ : 145.43 (-0.33%)
MRK : 76.72 (-2.11%)
TEVA : 19.41 (-4.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade JNJ with:

Business Summary

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin...

See More

Key Turning Points

2nd Resistance Point 148.85
1st Resistance Point 147.14
Last Price 145.43
1st Support Level 143.92
2nd Support Level 142.41

See More

52-Week High 148.99
Last Price 145.43
Fibonacci 61.8% 137.39
Fibonacci 50% 133.81
Fibonacci 38.2% 130.22
52-Week Low 118.62

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar